FI60862C - Foerfarande foer framstaellning av terapeutiskt anvaendbara aminoalkylidenamino-1,4-dihydropyridiner - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara aminoalkylidenamino-1,4-dihydropyridiner Download PDF

Info

Publication number
FI60862C
FI60862C FI772569A FI772569A FI60862C FI 60862 C FI60862 C FI 60862C FI 772569 A FI772569 A FI 772569A FI 772569 A FI772569 A FI 772569A FI 60862 C FI60862 C FI 60862C
Authority
FI
Finland
Prior art keywords
methyl
dihydropyridine
mmol
alkyl
formula
Prior art date
Application number
FI772569A
Other languages
English (en)
Finnish (fi)
Other versions
FI60862B (fi
FI772569A (fi
Inventor
Egbert Wehinger
Friedrich Bossert
Horst Meyer
Wulf Vater
Arend Heise
Stanislav Kazda
Kurt Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI772569A publication Critical patent/FI772569A/fi
Publication of FI60862B publication Critical patent/FI60862B/fi
Application granted granted Critical
Publication of FI60862C publication Critical patent/FI60862C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI772569A 1976-09-01 1977-08-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara aminoalkylidenamino-1,4-dihydropyridiner FI60862C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2639257 1976-09-01
DE19762639257 DE2639257A1 (de) 1976-09-01 1976-09-01 Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
FI772569A FI772569A (fi) 1978-03-02
FI60862B FI60862B (fi) 1981-12-31
FI60862C true FI60862C (fi) 1982-04-13

Family

ID=5986848

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772569A FI60862C (fi) 1976-09-01 1977-08-30 Foerfarande foer framstaellning av terapeutiskt anvaendbara aminoalkylidenamino-1,4-dihydropyridiner

Country Status (12)

Country Link
US (1) US4146627A (ja)
JP (1) JPS6026106B2 (ja)
AT (1) AT364359B (ja)
BE (1) BE858269A (ja)
CH (1) CH634053A5 (ja)
DE (1) DE2639257A1 (ja)
ES (1) ES461994A1 (ja)
FI (1) FI60862C (ja)
FR (1) FR2363554A1 (ja)
GB (1) GB1554495A (ja)
NL (1) NL7709508A (ja)
SE (1) SE7709797L (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2835069A1 (de) * 1978-08-10 1980-02-21 Bayer Ag N-amino-3,4,5-trihydroxypiperidine, ihre herstellung und verwendung
NZ193167A (en) 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS58131982A (ja) * 1982-02-01 1983-08-06 Tokyo Tanabe Co Ltd 新規なる１．４−ジヒドロピリジン誘導体
US4419518A (en) * 1982-07-26 1983-12-06 Tokyo Tanabe Co. L.T.D. 1,4-Dihydropyridine derivatives
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
GR851819B (ja) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
US5220027A (en) * 1987-04-14 1993-06-15 Sumitomo Chemical Company, Limited Sulfone-containing azamethide compounds with a nitrogen-containing aromatic ring of nitrogen containing aliphatic
US5028708A (en) * 1987-04-14 1991-07-02 Sumitomo Chemical Company, Limited Azamethinyl quinoline derivatives
GR1002248B (en) * 1988-03-08 1996-04-23 Egyt Gyogyszervegyeszeti Gyar 1,4-dihydropyridine derivatives preparation method
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
JP3394215B2 (ja) 1999-07-29 2003-04-07 株式会社 日立インダストリイズ フィルム減圧貼り合わせ装置
US7067226B2 (en) * 2001-03-29 2006-06-27 Hitachi Chemical Co., Ltd. Photosensitive film for circuit formation and process for producing printed wiring board

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946026A (en) * 1972-03-06 1976-03-23 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2239815C2 (de) * 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
JPS6026106B2 (ja) 1985-06-21
AT364359B (de) 1981-10-12
US4146627A (en) 1979-03-27
GB1554495A (en) 1979-10-24
BE858269A (fr) 1978-02-28
FI60862B (fi) 1981-12-31
NL7709508A (nl) 1978-03-03
SE7709797L (sv) 1978-03-02
FI772569A (fi) 1978-03-02
JPS5331670A (en) 1978-03-25
CH634053A5 (de) 1983-01-14
FR2363554A1 (fr) 1978-03-31
DE2639257A1 (de) 1978-03-02
FR2363554B1 (ja) 1980-08-08
ES461994A1 (es) 1978-12-01
ATA629677A (de) 1981-03-15

Similar Documents

Publication Publication Date Title
FI60862C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara aminoalkylidenamino-1,4-dihydropyridiner
FI61483B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,4-dihydropyridinkarboxylsyraalkylestrar
EP0172096B1 (fr) Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique
FI90543C (fi) Menetelmä lääkeaineina käyttökelpoisten dihydropyridiinin johdannaisten valmistamiseksi
AU5320200A (en) Npy antagonists: spiroisoquinolinone derivatives
IE51267B1 (en) 1,4-dihydropyridine compounds having different substituents in the 2-position and 6-position,their production,and their medicinal use
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
CZ99494A3 (en) Condensed quinolyl-dihydropyridines, process of their preparation, medicaments in which they are comprised, process of their preparation and the use of such compounds
JPS584715B2 (ja) 新規なアリ−ルトリフルオロエチルアミン
DK173807B1 (da) Fremgangsmåde til fremstilling af dihydropyridin-derivater
GB2058064A (en) Cns stimulants
IE922512A1 (en) Novel n-alkylated 1,4-dihydropyridinedicarboxylic acid¹esters
FR2528431A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
GB1568723A (en) Sulphur-containing amino-dihydropyridines process for their preparation and their use as medicaments
US4946862A (en) Thiophene derivative and process for preparing the same
JPH02169572A (ja) ジヒドロピリジンアミド及びその生理学的に許容し得る塩
CA1282411C (en) 1,4,5,6,7,8-hexahydroquinoline compounds
US5990121A (en) Use of 1,2-bridged 1,4-dihydropyridines as medicaments
CA2010529A1 (fr) Derives de la 1-arylsulfonyl 2-piperidinone, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions les renfermant
FI85491B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fosfonsyraderivat.
US4843085A (en) Pyridine derivatives, process for production thereof and pharmaceutical compositions useful as anti-arhytmics
US3988371A (en) Meta-[2-(benzylamino)-ethyl] benzoic acid amides
US4103095A (en) Cyclitolamines
KR0182276B1 (ko) 나프톡사진의 약학적 용도
JPH02169573A (ja) ４‐ニトロフエニル‐ジヒドロピリジンアミド

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT